Blue Letter on Xeplion Issued Following 21 Reported Deaths; Causal Relationship Remains Unclear

Meeting of Subcommittee on Safety of Drugs The Safety Division of the Ministry of Health, Labor and Welfare’s Pharmaceutical and Food Safety Bureau (PFSB) ordered Janssen Pharmaceutical on April 17 to distribute a flash safety report (blue letter) to medical...read more